Allianz Asset Management Gmb H Ultragenyx Pharmaceutical Inc. Transaction History

Allianz Asset Management Gmb H

$69.7 Billion
Q3 2024

A detailed history of Allianz Asset Management Gmb H transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 24,000 shares of RARE stock, worth $1.08 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,000

Previous 10,400 130.77%

Holding current value

$1.08 Million

Previous $427,000 212.18%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$40.21 - $59.36 $546,856 - $807,296	13,600 Added 130.77%	24,000 $1.33 Million
Q2 2024 Aug 13, 2024	SELL	$37.42 - $51.61 $104,776 - $144,508	-2,800 Reduced 21.21%	10,400 $427,000
Q1 2024 May 13, 2024	SELL	$43.02 - $53.69 $301,140 - $375,830	-7,000 Reduced 34.65%	13,200 $616,000
Q4 2023 Feb 12, 2024	BUY	$31.73 - $49.19 $371,241 - $575,523	11,700 Added 137.65%	20,200 $965,000
Q2 2023 Aug 11, 2023	BUY	$37.35 - $52.15 $317,475 - $443,275	8,500 New	8,500 $392,000
Q2 2022 Aug 12, 2022	SELL	$45.8 - $85.4 $474,716 - $885,171	-10,365 Reduced 28.9%	25,495 $1.52 Million
Q1 2022 May 13, 2022	BUY	$62.2 - $84.4 $166,198 - $225,516	2,672 Added 8.05%	35,860 $2.6 Million
Q4 2021 Feb 11, 2022	SELL	$73.71 - $87.86 $749,851 - $893,799	-10,173 Reduced 23.46%	33,188 $2.79 Million
Q3 2021 Nov 10, 2021	BUY	$77.92 - $102.4 $1.93 Million - $2.54 Million	24,799 Added 133.6%	43,361 $3.91 Million
Q2 2021 Aug 16, 2021	BUY	$92.19 - $115.71 $38,535 - $48,366	418 Added 2.3%	18,562 $1.77 Million
Q1 2021 May 13, 2021	SELL	$106.9 - $167.73 $49,387 - $77,491	-462 Reduced 2.48%	18,144 $2.07 Million
Q4 2020 Feb 16, 2021	BUY	$84.4 - $177.39 $400,056 - $840,828	4,740 Added 34.18%	18,606 $2.58 Million
Q3 2020 Nov 13, 2020	BUY	$72.98 - $90.0 $68,455 - $84,420	938 Added 7.26%	13,866 $1.14 Million
Q2 2020 Aug 14, 2020	BUY	$46.91 - $78.22 $606,452 - $1.01 Million	12,928 New	12,928 $1.01 Million
Q2 2019 Aug 08, 2019	SELL	$54.93 - $74.36 $1.72 Million - $2.33 Million	-31,364 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$39.87 - $69.36 $495,623 - $862,214	12,431 Added 65.66%	31,364 $2.18 Million
Q4 2018 Feb 14, 2019	BUY	$38.89 - $77.3 $736,304 - $1.46 Million	18,933 New	18,933 $823,000
Q3 2017 Nov 13, 2017	SELL	$49.79 - $66.32 $283,852 - $378,090	-5,701 Closed	0 $0
Q2 2017 Aug 14, 2017	SELL	N/A	-857 Reduced 13.07%	5,701 $354,000
Q1 2017 Apr 17, 2019	SELL	N/A	-2,001 Reduced 23.38%	6,558 $445,000
Q4 2016 Apr 17, 2019	SELL	N/A	-11,029 Reduced 56.3%	8,559 $602,000
Q3 2016 Apr 17, 2019	BUY	N/A	19,588	19,588 $1.39 Million

Others Institutions Holding RARE

# of Institutions

326

Shares Held

85.7M

Call Options Held

520K

Put Options Held

406K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.15B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.

Account

Allianz Asset Management Gmb H Ultragenyx Pharmaceutical Inc. Transaction History